Inside the Science of a Groundbreaking Universal Snakebite Cure

Over two decades, one brave man turned his body into a living science experiment. Using self-immunization, Tim Friede willingly exposed himself to some of the world’s deadliest snake venoms. Friede’s journey to build immunity has led to a scientific breakthrough: universal antivenom. Researchers have used Friede’s antibodies, or protective proteins, to develop one of the most broadly effective antivenoms to date.

Snakebites and Antivenoms: A Deadly Problem

Snakebites are a serious global health issue, especially in rural parts of the world where healthcare is not as accessible. Each venomous snake has a unique blend of toxins, which makes treating snakebites challenging. To illustrate, the conventional method of creating antivenom starts by injecting a large animal (often horses or sheep) with venom from one snake species. Next, antibodies are harvested from that same animal’s immune system. Even though these horse-derived antivenoms can save lives, they come with many drawbacks. Because the antibodies are non-human, patients can suffer severe reactions to the non-human antibodies. Additionally, each antivenom works only against specific snake species or those in a particular region.

Friede’s brave methods provided scientists with another option. Instead of relying on many different antivenoms and the risky process of administering non-human antibodies to humans, these human antibodies could be broadly effective or used for a range of different snake bites.

Friede subjected himself to hundreds of snakebites and venom injections from dozens of venomous snakes. In doing this, he created antibodies that responded to a vast array of toxins. Friede’s antibodies essentially formed a library of anti-venom defenses. Characterized as “neutralizing antibodies”, these proteins in his immune system laid the groundwork to greatly improve antivenom medicine on a global scale.

A Universal Antivenom

To help improve antivenoms, scientists had to determine which of Friede’s antibodies could stop snake venoms. First, they compiled a panel of 19 of the world’s deadliest snake venoms. Using this diverse venom panel, the team got to work using Friede’s blood.

Researchers isolated antibodies from his blood that reacted strongly to the selected venoms. In simpler terms, they used his antibodies like a lock and key match for each toxin. In Friede’s case, there were many different keys for each venom lock. Finally, after mapping out the effective antibodies, the scientists formulated a mix of ingredients to disable the tested venoms. Let’s break down those components.

• LNX-D09 – goes after part of the venom that breaks down tissue and blood vessels (lab-made antibody)

• Varespladib – works against aggressive venom enzymes

• SNX-B03 – focuses on venom that messes with your blood (causes internal bleeding/clotting)

Moreover, after creating this “antivenom cocktail”, it was tested in mouse models and provided full protection against venom from 13 to 19 dangerous snake species tested.

From Mouse Trials to Real-World

Additionally, achieving broad protection in the lab is a huge milestone, however, the ultimate goal is to save lives in the real world. Now, the research team’s goal is to move the antivenom from the lab into the field. One of the first steps of this testing process is to evaluate the antivenom in a real-life scenario. This could look like treating canine cases. Since around 150,000 pets are bitten by venomous snakes each year, this would be a seamless way to test the antivenom. Collecting this data would provide insights into how the antivenom works outside of the mouse models. Specifically, this will help determine proper safety, dosing, and efficacy in a setting that is adjacent to human medical use.

Developing this antivenom and getting it to those in need is not only a scientific challenge but also a financial and logistical one. Support for clinical trials and manufacturing would be necessary. If the antibodies prove to be completely safe, navigating approvals and securing funding can still be a tricky process.

A Quest For Global Health

How astounding is it that one man’s quest might tip the scale and become the cornerstone for a global medical breakthrough? Friede’s blood provided crucial ingredients to create an antivenom with “unprecedented breadth”.

The science that emerged from this contribution is from a man with an interesting history, who showed that human proteins can be used to neutralize venom. Specifically, early research suggests that a single antivenom injection could potentially treat bites from cobras, mambas, or kraits, though this has only been demonstrated in animal models so far and is not yet approved for human use. This research not only provides hope but also represents significant progress toward a universal treatment of this global health issue, which is a truly promising step forward.

The post Inside the Science of a Groundbreaking Universal Snakebite Cure appeared first on A-Z Animals.